Proteostasis Therapeutics
AcquiredBoston, United States · Founded 2006 · $45.0M raised
- Headquarters
- Boston, Massachusetts
- Employees
- 11–50
- Founded
- 2006
- Business Model
- B2B
- Total Funding
- $45.0M
- Last Round
- $45.0M Series AAug 2008
- Rounds
- 1
About
Proteostasis Therapeutics was a clinical-stage biopharmaceutical company focused on discovering and developing small-molecule therapeutics to treat cystic fibrosis and other diseases caused by dysfunctional protein processing. Founded in 2006 and based in Boston, Massachusetts, the company traded on Nasdaq under the ticker PTI. After its CF drug candidates underperformed against Vertex's pipeline, Proteostasis merged with Yumanity Therapeutics in 2020.
Summary
Proteostasis Therapeutics is a Biotech company based in Boston, United States, founded in 2006. It has raised $45.0M in total across 1 round, most recently a $45.0M Series A round in Aug 2008. Investors include New Enterprise Associates, HealthCare and Fidelity Biosciences.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Dec 2020
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.